Free Trial

Balyasny Asset Management L.P. Acquires Shares of 272,462 American Healthcare REIT, Inc. (NYSE:AHR)

American Healthcare REIT logo with Finance background

Balyasny Asset Management L.P. acquired a new stake in American Healthcare REIT, Inc. (NYSE:AHR - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 272,462 shares of the company's stock, valued at approximately $7,743,000. Balyasny Asset Management L.P. owned 0.18% of American Healthcare REIT as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of AHR. Vanguard Group Inc. grew its stake in shares of American Healthcare REIT by 94.8% during the 4th quarter. Vanguard Group Inc. now owns 15,357,331 shares of the company's stock worth $436,455,000 after purchasing an additional 7,474,374 shares during the period. Principal Financial Group Inc. grew its stake in shares of American Healthcare REIT by 54.1% during the 3rd quarter. Principal Financial Group Inc. now owns 9,488,750 shares of the company's stock worth $247,654,000 after purchasing an additional 3,330,714 shares during the period. Cbre Investment Management Listed Real Assets LLC acquired a new stake in shares of American Healthcare REIT during the 4th quarter worth approximately $33,838,000. Geode Capital Management LLC grew its stake in shares of American Healthcare REIT by 46.4% during the 4th quarter. Geode Capital Management LLC now owns 3,699,793 shares of the company's stock worth $105,171,000 after purchasing an additional 1,172,670 shares during the period. Finally, Northern Trust Corp grew its stake in shares of American Healthcare REIT by 99.0% during the 4th quarter. Northern Trust Corp now owns 1,732,882 shares of the company's stock worth $49,249,000 after purchasing an additional 861,882 shares during the period. Hedge funds and other institutional investors own 16.68% of the company's stock.

American Healthcare REIT Trading Down 0.4%

AHR traded down $0.13 on Tuesday, hitting $34.62. The company had a trading volume of 1,449,804 shares, compared to its average volume of 1,818,972. The firm has a market cap of $5.45 billion, a P/E ratio of -72.13, a PEG ratio of 1.57 and a beta of 1.40. American Healthcare REIT, Inc. has a 1 year low of $13.67 and a 1 year high of $35.13. The company's fifty day moving average price is $30.29 and its 200 day moving average price is $28.88. The company has a current ratio of 0.37, a quick ratio of 0.37 and a debt-to-equity ratio of 0.59.

American Healthcare REIT (NYSE:AHR - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.37 by $0.01. The company had revenue of $540.60 million for the quarter, compared to analyst estimates of $542.32 million. American Healthcare REIT had a negative net margin of 1.84% and a negative return on equity of 1.87%. The business's revenue for the quarter was up 8.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.30 earnings per share. As a group, equities analysts expect that American Healthcare REIT, Inc. will post 1.41 earnings per share for the current year.

American Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, April 17th. Shareholders of record on Monday, March 31st were issued a dividend of $0.25 per share. The ex-dividend date of this dividend was Monday, March 31st. This represents a $1.00 dividend on an annualized basis and a yield of 2.89%. American Healthcare REIT's dividend payout ratio (DPR) is presently -370.37%.

Analyst Upgrades and Downgrades

AHR has been the topic of a number of research analyst reports. KeyCorp dropped their price target on shares of American Healthcare REIT from $35.00 to $34.00 and set an "overweight" rating on the stock in a research note on Monday, March 31st. Morgan Stanley lifted their price target on shares of American Healthcare REIT from $36.00 to $37.00 and gave the company an "overweight" rating in a research note on Tuesday, March 25th. JMP Securities set a $35.00 price target on shares of American Healthcare REIT in a research note on Tuesday, March 4th. Jefferies Financial Group initiated coverage on shares of American Healthcare REIT in a research note on Monday, April 28th. They issued a "buy" rating and a $37.00 price target on the stock. Finally, Citigroup reissued an "outperform" rating on shares of American Healthcare REIT in a research note on Tuesday, March 4th. Eight research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $33.86.

Read Our Latest Report on American Healthcare REIT

About American Healthcare REIT

(Free Report)

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

Further Reading

Institutional Ownership by Quarter for American Healthcare REIT (NYSE:AHR)

Should You Invest $1,000 in American Healthcare REIT Right Now?

Before you consider American Healthcare REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.

While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs Warns of 20% Market Drop—Are They Right?
Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines